HU900701D0 - New galenic preparations containing cyclosporine - Google Patents

New galenic preparations containing cyclosporine

Info

Publication number: HU900701D0
Authority: HU; Hungary
Prior art keywords: preparations containing; galenic preparations; containing cyclosporine; new galenic; new
Prior art date: 1989-02-09

Application number

HU90701A

Other languages

English (en)

Other versions

HU213394B (en

Inventor

Birgit Hauer

Ulrich Posanski

Original Assignee

Sandoz Technology Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1989-02-09

Filing date

1990-02-07

Publication date

1990-04-28

1989-02-09 Priority claimed from GB898902901A external-priority patent/GB8902901D0/en

1989-02-09 Priority claimed from GB898902898A external-priority patent/GB8902898D0/en

1989-02-13 Priority claimed from GB898903147A external-priority patent/GB8903147D0/en

1989-02-17 Priority claimed from GB898903663A external-priority patent/GB8903663D0/en

1990-02-07 Application filed by Sandoz Technology Ltd filed Critical Sandoz Technology Ltd

1990-04-28 Publication of HU900701D0 publication Critical patent/HU900701D0/hu

1997-06-30 Publication of HU213394B publication Critical patent/HU213394B/hu

Links

PMATZTZNYRCHOR-CGLBZJNRSA-N Cyclosporin A Chemical compound CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)C\C=C\C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C1=O PMATZTZNYRCHOR-CGLBZJNRSA-N 0.000 title 1
108010036949 Cyclosporine Proteins 0.000 title 1
229960001265 ciclosporin Drugs 0.000 title 1
229930182912 cyclosporin Natural products 0.000 title 1
238000002360 preparation method Methods 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4866—Organic macromolecular compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
- A61K38/13—Cyclosporins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/485—Inorganic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Engineering & Computer Science (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Epidemiology (AREA)
Immunology (AREA)
Gastroenterology & Hepatology (AREA)
Molecular Biology (AREA)
Physical Education & Sports Medicine (AREA)
Orthopedic Medicine & Surgery (AREA)
Rheumatology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Biochemistry (AREA)
Pain & Pain Management (AREA)
Oil, Petroleum & Natural Gas (AREA)
Biophysics (AREA)
Transplantation (AREA)
Tropical Medicine & Parasitology (AREA)
Neurology (AREA)
Diabetes (AREA)
Hematology (AREA)
Dermatology (AREA)
Inorganic Chemistry (AREA)
Medicinal Preparation (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

HU90701A 1989-02-09 1990-02-07 Process for producing pharmaceutical compositions containing cyclosporins as active components HU213394B (en)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
GB898902901A GB8902901D0 (en)	1989-02-09	1989-02-09	Improvements in or relating to organic compounds
GB898902898A GB8902898D0 (en)	1989-02-09	1989-02-09	Improvements in or relating to organic compounds
GB898903147A GB8903147D0 (en)	1989-02-13	1989-02-13	Improvements in or relating to organic compounds
GB898903663A GB8903663D0 (en)	1989-02-17	1989-02-17	Improvements in or relating to organic compounds

Publications (2)

Publication Number	Publication Date
HU900701D0 true HU900701D0 (en)	1990-04-28
HU213394B HU213394B (en)	1997-06-30

Family

ID=27450262

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
HU90701A HU213394B (en)	1989-02-09	1990-02-07	Process for producing pharmaceutical compositions containing cyclosporins as active components

Country Status (25)

Country	Link
JP (3)	JP3484190B2 (hu)
KR (1)	KR0170769B1 (hu)
AT (1)	AT404552B (hu)
AU (1)	AU630413B2 (hu)
BE (1)	BE1003009A5 (hu)
CA (1)	CA2009533C (hu)
CH (1)	CH679277A5 (hu)
CY (1)	CY1903A (hu)
DE (1)	DE4003844B4 (hu)
DK (1)	DK176209B1 (hu)
ES (1)	ES2021942A6 (hu)
FI (1)	FI97524C (hu)
FR (1)	FR2642650B1 (hu)
GB (1)	GB2230440B (hu)
HK (1)	HK37296A (hu)
HU (1)	HU213394B (hu)
IT (1)	IT1240758B (hu)
LU (1)	LU87675A1 (hu)
MY (1)	MY107377A (hu)
NL (1)	NL195028C (hu)
NO (1)	NO301576B1 (hu)
NZ (1)	NZ232401A (hu)
PH (1)	PH30917A (hu)
PT (1)	PT93079B (hu)
SE (1)	SE511398C2 (hu)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
KR0148748B1 (ko) *	1988-09-16	1998-08-17	장 크라메르, 한스 루돌프 하우스	사이클로스포린을 함유하는 약학조성물
HU208491B (en) *	1990-11-27	1993-11-29	Gyogyszerkutato Intezet	Process for producing oral pharmaceutical composition containing cyclosporin
MX9201782A (es) †	1991-04-19	1992-10-01	Sandoz Ag	Particulas de sustancias biologicamente activas, sustancialmente insolubles en agua, proceso para su produccion y composicion farmaceutica que las contiene.
US6262022B1 (en)	1992-06-25	2001-07-17	Novartis Ag	Pharmaceutical compositions containing cyclosporin as the active agent
GB9113872D0 (en) *	1991-06-27	1991-08-14	Sandoz Ag	Improvements in or relating to organic compounds
DK0642332T3 (da)	1992-05-13	1997-06-16	Sandoz Ltd	Ophthalmiske præparater indeholdende cyclosporin
US5759566A (en) *	1992-07-28	1998-06-02	Poli Industria Chimica Spa	Microemulsion pharmaceutical compositions for the delivery of pharmaceutically active agents
EP1142568A1 (en)	1992-09-25	2001-10-10	Novartis AG	Pharmaceutical compositions containing cyclosporins
DE4412201A1 (de) *	1993-04-20	1994-11-10	Rentschler Arzneimittel	Neue pharmazeutische Zubereitungen zur oralen Verabreichung enthaltend Cyclosporin
HUT72738A (en) *	1993-04-20	1996-05-28	Rentschler Arzneimittel	New cyclosporine-containing pharmaceutical compositions for oral administration
DE4340781C3 (de) *	1993-11-30	2000-01-27	Novartis Ag	Cyclosporin enthaltende flüssige Zubereitungen und Verfahren zu ihrer Herstellung
KR0146671B1 (ko) *	1994-02-25	1998-08-17	김충환	사이클로스포린-함유 분말 조성물
EE03425B1 (et)	1994-11-03	2001-06-15	Arzneimittelwerk Dresden Gmbh	Lihtsa koostise ja kõrge biosaadavusega tsüklosporiini preparaadid suu kaudu manustamiseks ja nende valmistamismeetod
US5679566A (en) *	1995-01-20	1997-10-21	University Of Massachusetts Medical Center	Yeast NMD2 gene
US5827822A (en) *	1996-03-25	1998-10-27	Sangstat Medical Corporation	Cyclosporin a formulations as nanoparticles
US5834017A (en) *	1995-08-25	1998-11-10	Sangstat Medical Corporation	Oral cyclopsporin formulations
US5766629A (en)	1995-08-25	1998-06-16	Sangstat Medical Corporation	Oral cyclosporin formulations
US5962019A (en) *	1995-08-25	1999-10-05	Sangstat Medical Corporation	Oral cyclosporin formulations
DE19544507B4 (de)	1995-11-29	2007-11-15	Novartis Ag	Cyclosporin enthaltende Präparate
US5798333A (en) *	1996-09-17	1998-08-25	Sherman; Bernard C.	Water-soluble concentrates containing cyclosporins
AU762247B2 (en) *	1997-01-30	2003-06-19	Novartis Ag	Oil-free pharmaceutical compositions containing cyclosporin A
NZ336900A (en) *	1997-01-30	2001-06-29	Novartis Ag	Hard gelatine capsules containing pharmaceutical compositions comprising cyclosporin A and being substantially free of any oil
ATE286403T1 (de) *	1997-03-12	2005-01-15	Abbott Lab	Hydrophile binäre systeme zur verabreichung von cyclosporin
NZ328751A (en) *	1997-09-16	1999-01-28	Bernard Charles Sherman	Solid medicament containing an anionic surfactant and cyclosporin
US6447806B1 (en)	1999-02-25	2002-09-10	Novartis Ag	Pharmaceutical compositions comprised of stabilized peptide particles
KR100978836B1 (ko)	2001-10-19	2010-08-30	이소테크니카 인코포레이티드	신규한 시클로스포린 유사체 미세유화액 예비농축물
US6979672B2 (en)	2002-12-20	2005-12-27	Polichem, S.A.	Cyclosporin-based pharmaceutical compositions
JP4521554B2 (ja) *	2004-03-31	2010-08-11	マイラン製薬株式会社	シクロスポリン製剤
WO2007050975A2 (en) *	2005-10-26	2007-05-03	Banner Pharmacaps, Inc.	Hydrophilic vehicle-based dual controlled release matrix system as capsule fill
KR20140038575A (ko) *	2006-03-28	2014-03-28	자블린 파머슈티칼스 인코포레이티드	저 복용량의 디클로페낙 및 베타-사이클로덱스트린 제형
US7495024B2 (en)	2006-08-07	2009-02-24	Via Pharmaceuticals, Inc.	Phenylalkyl N-hydroxyureas for combating atherosclerotic plaque
DE102008059201A1 (de)	2008-11-27	2010-06-02	GÖPFERICH, Achim, Prof. Dr.	In situ präzipitierende Arzneistofflösungen
KR102146704B1 (ko)	2018-04-13	2020-08-21	가천대학교 산학협력단	사이클로스포린 A (CsA) 경피 및 피내 약물전달용 마이크로구조체
EP4166133B1 (en) *	2021-10-13	2025-07-23	Chugai Seiyaku Kabushiki Kaisha	Composition containing peptide compound and surfactant
WO2023214509A1 (ja) *	2022-05-02	2023-11-09	中外製薬株式会社	界面活性剤と併用するためのペプチド化合物を含む組成物

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FI65914C (fi) *	1978-03-07	1984-08-10	Sandoz Ag	Foerfarande foer framstaellning av farmaceutiska kompositionerinnehaollande cyklosporin a
JPS61280435A (ja) *	1985-04-04	1986-12-11	Kanji Takada	サイクロスポリン類のリンパ指向性製剤
NL8600050A (nl) *	1986-01-13	1987-08-03	Sanico Nv	Farmaceutisch preparaat met vertraagde afgifte van het werkzame bestanddeel en werkwijze voor de bereiding er van.
GB8602372D0 (en) *	1986-01-31	1986-03-05	Sandoz Ltd	Organic compounds
CA1290249C (en) *	1986-04-09	1991-10-08	Cetus Corporation	COMBINATION THERAPY USING INTERLEUKIN-2 AND/OR INTERFERON-.beta. AND TUMOR NECROSIS FACTOR
CA1341374C (en) *	1986-11-13	2002-07-09	Alan N. Houghton	Compositions and method for treatment of cancer using monoclonal antibody against gd3 ganglioside together with il-2
EP0296122B1 (en) *	1987-06-17	1993-09-29	Sandoz Ag	Cyclosporins and their use as pharmaceuticals
JP2536876B2 (ja) *	1987-07-31	1996-09-25	寛治高田	シクロスポリンの溶解性粉末状製剤
DE3830494B4 (de) *	1987-09-15	2006-05-18	Novartis Ag	Wasserlösliche Monoester als Solubilisatoren für pharmakologische Wirkstoffe und pharmazeutische Hilfsstoffe
HU205010B (en) *	1987-09-15	1992-03-30	Sandoz Ag	Process for producing pharmaceutical compositions comprising compounds soluble up to 1 per cent and having medical activity
US5756450A (en) *	1987-09-15	1998-05-26	Novartis Corporation	Water soluble monoesters as solubilisers for pharmacologically active compounds and pharmaceutical excipients and novel cyclosporin galenic forms
JP2792862B2 (ja) *	1988-07-30	1998-09-03	寛治高田	経口腸溶製剤
KR0148748B1 (ko) *	1988-09-16	1998-08-17	장 크라메르, 한스 루돌프 하우스	사이클로스포린을 함유하는 약학조성물
JPH1038029A (ja) *	1996-07-26	1998-02-13	Ebara Corp	制振機能付き円板状構造物
JPH10280435A (ja) *	1997-04-03	1998-10-20	Sekisui Chem Co Ltd	地下室の構築方法

1990
- 1990-02-05 BE BE9000133A patent/BE1003009A5/fr not_active IP Right Cessation
- 1990-02-05 GB GB9002504A patent/GB2230440B/en not_active Expired - Lifetime
- 1990-02-05 FR FR9001389A patent/FR2642650B1/fr not_active Expired - Lifetime
- 1990-02-05 CH CH359/90A patent/CH679277A5/de not_active IP Right Cessation
- 1990-02-07 PT PT93079A patent/PT93079B/pt not_active IP Right Cessation
- 1990-02-07 CA CA002009533A patent/CA2009533C/en not_active Expired - Lifetime
- 1990-02-07 HU HU90701A patent/HU213394B/hu unknown
- 1990-02-07 MY MYPI90000191A patent/MY107377A/en unknown
- 1990-02-07 PH PH40014A patent/PH30917A/en unknown
- 1990-02-07 FI FI900604A patent/FI97524C/fi active IP Right Grant
- 1990-02-07 DK DK199000327A patent/DK176209B1/da not_active IP Right Cessation
- 1990-02-07 NZ NZ232401A patent/NZ232401A/en unknown
- 1990-02-07 SE SE9000441A patent/SE511398C2/sv not_active Application Discontinuation
- 1990-02-07 NO NO900577A patent/NO301576B1/no not_active IP Right Cessation
- 1990-02-07 LU LU87675A patent/LU87675A1/fr unknown
- 1990-02-08 AT AT0027290A patent/AT404552B/de not_active IP Right Cessation
- 1990-02-08 DE DE4003844A patent/DE4003844B4/de not_active Expired - Lifetime
- 1990-02-08 KR KR1019900001492A patent/KR0170769B1/ko not_active Expired - Lifetime
- 1990-02-08 JP JP03134890A patent/JP3484190B2/ja not_active Expired - Lifetime
- 1990-02-08 IT IT47609A patent/IT1240758B/it active IP Right Grant
- 1990-02-08 NL NL9000299A patent/NL195028C/nl not_active IP Right Cessation
- 1990-02-08 AU AU49252/90A patent/AU630413B2/en not_active Expired
- 1990-02-09 ES ES9000397A patent/ES2021942A6/es not_active Expired - Lifetime
1996
- 1996-03-07 HK HK37296A patent/HK37296A/xx not_active IP Right Cessation
- 1996-11-22 CY CY190396A patent/CY1903A/en unknown
2001
- 2001-04-25 JP JP2001127538A patent/JP4073641B2/ja not_active Expired - Lifetime
2005
- 2005-09-13 JP JP2005265724A patent/JP2006001947A/ja active Pending

Also Published As

Publication number	Publication date
FI97524C (fi)	1997-01-10
NO900577L (no)	1990-08-10
IT9047609A0 (it)	1990-02-08
NO301576B1 (no)	1997-11-17
FR2642650A1 (fr)	1990-08-10
FI97524B (fi)	1996-09-30
DE4003844A1 (de)	1990-08-16
NL195028C (nl)	2003-12-02
ATA27290A (de)	1998-05-15
AT404552B (de)	1998-12-28
GB9002504D0 (en)	1990-04-04
NZ232401A (en)	1992-10-28
PT93079A (pt)	1990-08-31
JPH02235817A (ja)	1990-09-18
PT93079B (pt)	1996-04-30
SE511398C2 (sv)	1999-09-20
JP2001302538A (ja)	2001-10-31
SE9000441L (sv)	1991-08-08
FI900604A0 (fi)	1990-02-07
DK32790A (da)	1990-08-10
DE4003844B4 (de)	2007-09-20
KR900012625A (ko)	1990-09-01
IT1240758B (it)	1993-12-17
JP4073641B2 (ja)	2008-04-09
GB2230440A (en)	1990-10-24
AU4925290A (en)	1990-08-16
CA2009533A1 (en)	1990-08-09
AU630413B2 (en)	1992-10-29
CY1903A (en)	1996-11-22
CH679277A5 (hu)	1992-01-31
CA2009533C (en)	2002-11-12
PH30917A (en)	1997-12-23
NL195028B (nl)	2003-08-01
BE1003009A5 (fr)	1991-10-22
SE9000441D0 (sv)	1990-02-07
GB2230440B (en)	1993-05-19
JP2006001947A (ja)	2006-01-05
NL9000299A (nl)	1990-09-03
HU213394B (en)	1997-06-30
KR0170769B1 (ko)	1999-02-01
HK37296A (en)	1996-03-15
LU87675A1 (fr)	1991-10-08
MY107377A (en)	1995-11-30
JP3484190B2 (ja)	2004-01-06
FR2642650B1 (fr)	1994-12-09
ES2021942A6 (es)	1991-11-16
NO900577D0 (no)	1990-02-07
DK32790D0 (da)	1990-02-07
DK176209B1 (da)	2007-02-05
IT9047609A1 (it)	1991-08-08

Publication	Publication Date	Title
HU900701D0 (en)	1990-04-28	New galenic preparations containing cyclosporine
GB2228198B (en)	1992-12-16	Novel cyclosporin galenic forms
IL91642A0 (en)	1990-04-29	Pharmaceutical compositions comprising cyclosporins
PH23446A (en)	1989-08-07	Peptide preparations
EP0355247A3 (en)	1990-12-12	Compressed-molded preparations
HU911672D0 (en)	1991-11-28	Tfg-beta preparations
EP0416527A3 (en)	1992-10-14	Prostaglandin-containing liposome preparations
GB8719375D0 (en)	1987-09-23	Pharmaceutical preparations
ZA906186B (en)	1991-06-26	Pharmaceutical preparations
GB8906129D0 (en)	1989-05-04	Pharmaceutical preparations
AU5653790A (en)	1990-12-18	Cosmetic preparations
ZA877825B (en)	1988-04-20	"peptide preparations"
ZA904021B (en)	1991-02-27	Slimming preparations
IL93589A0 (en)	1990-12-23	Bisphenethanolamine,its preparation and preparations containing it
ZA875281B (en)	1988-03-30	Zylometzoline-containing pharmaceutical preparations
GB8914613D0 (en)	1989-08-16	Pharmaceutical preparations
GB8914610D0 (en)	1989-08-16	Pharmaceutical preparations
GB8914612D0 (en)	1989-08-16	Pharmaceutical preparations
IE890022L (en)	1989-07-06	Pharmaceutical preparations
IE890944L (en)	1989-09-24	Pharmaceutical preparations
GB8914611D0 (en)	1989-08-16	Pharmaceutical preparations
IE892741L (en)	1990-09-18	Pharmaceutical combination preparations
IE861311L (en)	1986-11-17	Pharmaceutical preparations
GB8603271D0 (en)	1986-03-19	Pharmaceutical preparations
IE873302L (en)	1988-06-06	Pharmaceutical preparations

Legal Events

Date	Code	Title	Description
1997-11-28	HPC4	Succession in title of patentee	Owner name: NOVARTIS AG, CH